German sports car manufacturer Porsche experienced its worst annual sales performance in 16 years, according to Reuters, delivering 279,449 vehicles in 2025—a 10% decline compared to 2024. The luxury automaker, a Volkswagen subsidiary, joins fellow German manufacturers Audi and Mercedes-Benz in grappling with challenging market conditions, particularly in China where Porsche sales plummeted 26%. Reuters… Continue reading Porsche Reports Steepest Sales Decline Since 2009-Report
Tag: Strategy
Hyundai Taps Former Tesla Robotics Leader to Bolster AI and Humanoid Robot Strategy
Hyundai Motor Group is bringing aboard Milan Kovac, who previously led Tesla’s Optimus humanoid robot program, as the South Korean automaker accelerates its push into robotics and artificial intelligence, according to Reuters. Kovac will serve as an adviser to Hyundai Motor Group and is slated to become an outside director at Boston Dynamics, the company’s… Continue reading Hyundai Taps Former Tesla Robotics Leader to Bolster AI and Humanoid Robot Strategy
IBM Study: AI Poised to Drive Smarter Business Growth Through 2030
By 2030, surveyed executives anticipate AI spend to shift from efficiency to innovation AI productivity gains projected to increase by 42%, fueling reinvestment for growth 67% of respondents expect AI to eliminate resource and skills constraints ARMONK, N.Y., Jan. 19, 2026 /PRNewswire/ — New research from the IBM (NYSE: IBM) Institute for Business Value reveals… Continue reading IBM Study: AI Poised to Drive Smarter Business Growth Through 2030
W. LUNABELLA Elevates K-Beauty: Unveils Premier ‘Total Beauty Solution Hub’ in Paris’ Iconic Le Marais
PARIS, Jan. 19, 2026 /PRNewswire/ — LUNABELLA, a visionary force in K-Beauty, today announces the monumental grand opening of its flagship “W. LUNABELLA” in Paris’ historic Le Marais district this March, perfectly timed with Paris Fashion Week. More than a conventional boutique, this sprawling sanctuary is meticulously crafted as a “Total Beauty Solution Hub” –… Continue reading W. LUNABELLA Elevates K-Beauty: Unveils Premier ‘Total Beauty Solution Hub’ in Paris’ Iconic Le Marais
/C O R R E C T I O N — Ampace/
In the news release, Ampace and DG Matrix Announce Strategic Partnership to Deliver First UL-Certified Grid-Active BESS Integrated with Multi-Port Solid-State Transformer Architecture for AI Data Centers, issued 17-Dec-2025 by Ampace over PR Newswire, we are advised by the company that the 6th paragraph, first sentence, should read “Brad Li, President of Ampace Americas Region,… Continue reading /C O R R E C T I O N — Ampace/
Chassis Supply Chain’s “iPhone Moment”: China’s Tier 1 Shift as LeeKr Emerges
SHANGHAI, Jan. 19, 2026 /PRNewswire/ — Over the past decade, China’s electric vehicle (EV) industry has evolved from a niche experiment into a leading force in the global automotive landscape. In the first ten months of 2025, China exported over 2 million EVs, nearly double the year-earlier figure. From European city streets to Southeast Asian highways… Continue reading Chassis Supply Chain’s “iPhone Moment”: China’s Tier 1 Shift as LeeKr Emerges
D3 Bio Receives U.S. FDA Clearance for Two IND Applications, Enabling Phase 1 Trial of D3S‑003 and Phase 2 Combination Study of Elisrasib (D3S‑001) with D3S‑002
SHANGHAI, Jan. 18, 2026 /PRNewswire/ — D3 Bio, a global clinical‑stage biotechnology company focused on developing transformative oncology therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has cleared two Investigational New Drug (IND) applications: D3S‑003 — a KRAS G12D inhibitor — enabling the start of a Phase 1 first‑in‑human clinical trial. A Phase… Continue reading D3 Bio Receives U.S. FDA Clearance for Two IND Applications, Enabling Phase 1 Trial of D3S‑003 and Phase 2 Combination Study of Elisrasib (D3S‑001) with D3S‑002
Harbour BioMed Acquires Common Stock in Spruce Biosciences, Deepening Strategic Collaboration
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Jan. 18, 2026 /PRNewswire/ — Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, today announced that through its wholly-owned subsidiary, it has exercised its warrant to acquire the common stock in Spruce Biosciences, Inc. (Nasdaq: SPRB) (“Spruce”). Following… Continue reading Harbour BioMed Acquires Common Stock in Spruce Biosciences, Deepening Strategic Collaboration
Elliott Opposes Toyota Fudosan’s Revised Tender Offer for Toyota Industries Corporation
In the letter, Elliott outlined its opposition to the revised tender offer by Toyota Fudosan Co., Ltd. at ¥18,800 per share (the “Revised TOB”), which Elliott believes very significantly undervalues Toyota Industries. Elliott’s analysis showed the Company’s intrinsic net asset value to be more than ¥26,000 per share as of January 16, 2026 – almost… Continue reading Elliott Opposes Toyota Fudosan’s Revised Tender Offer for Toyota Industries Corporation
@VW Group: Porsche opens new Studio in the heart of Istanbul011253
16/12/2025 The new Porsche Studio Istanbul showcases the new Cayenne Electric for the first time in Turkey. Porsche AG is unveiling one of its most comprehensive applications of Porsche’s global Studio concept in the heart of Istanbul, Etiler. A collaboration between Porsche Central and Eastern Europe (PCEE) and Doğuş Otomotiv (Porsche Türkiye), Porsche Studio Istanbul… Continue reading @VW Group: Porsche opens new Studio in the heart of Istanbul011253